Department of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Department of Ophthalmology, Duke Eye Center, Durham, NC, 27710, USA.
Sci Rep. 2020 May 13;10(1):7912. doi: 10.1038/s41598-020-64827-2.
We acquired depth-resolved light scattering measurements from the retinas of triple transgenic Alzheimer's Disease (3xTg-AD) mice and wild type (WT) age-matched controls using co-registered angle-resolved low-coherence interferometry (a/LCI) and optical coherence tomography (OCT). Angle-resolved light scattering measurements were acquired from the nerve fiber layer, outer plexiform layer, and retinal pigmented epithelium using image guidance and segmented thicknesses provided by co-registered OCT B-scans. Analysis of the OCT images showed a statistically significant thinning of the nerve fiber layer in AD mouse retinas compared to WT controls. The a/LCI scattering measurements provided complementary information that distinguishes AD mice by quantitatively characterizing tissue heterogeneity. The AD mouse retinas demonstrated higher mean and variance in nerve fiber layer light scattering intensity compared to WT controls. Further, the difference in tissue heterogeneity was observed through short-range spatial correlations that show greater slopes at all layers of interest for AD mouse retinas compared to WT controls. A greater slope indicates a faster loss of spatial correlation, suggesting a loss of tissue self-similarity characteristic of heterogeneity consistent with AD pathology. Use of this combined modality introduces unique tissue texture characterization to complement development of future AD biomarker analysis.
我们使用共配准角度分辨低相干干涉测量(a/LCI)和光相干断层扫描(OCT)从三转基因阿尔茨海默病(3xTg-AD)小鼠和野生型(WT)年龄匹配的对照的视网膜中获得了深度分辨的光散射测量。使用图像引导和共配准 OCT B 扫描提供的分段厚度,从神经纤维层、外丛状层和视网膜色素上皮层获取角度分辨的光散射测量。OCT 图像分析表明,与 WT 对照相比,AD 小鼠的神经纤维层明显变薄。a/LCI 散射测量提供了补充信息,可以通过定量表征组织异质性来区分 AD 小鼠。与 WT 对照相比,AD 小鼠的神经纤维层光散射强度的平均值和方差更高。此外,通过短程空间相关性观察到组织异质性的差异,表明 AD 小鼠的所有感兴趣层的斜率都更大,与 WT 对照相比。斜率越大表明空间相关性的丧失越快,这表明组织自相似性的丧失与 AD 病理学一致的异质性特征。这种组合模态的使用引入了独特的组织纹理特征,以补充未来 AD 生物标志物分析的发展。